Freedom Day Solutions LLC Buys 493 Shares of PerkinElmer, Inc. (NYSE:PKI)

Freedom Day Solutions LLC raised its stake in shares of PerkinElmer, Inc. (NYSE:PKIGet Rating) by 6.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,949 shares of the medical research company’s stock after buying an additional 493 shares during the period. Freedom Day Solutions LLC’s holdings in PerkinElmer were worth $1,598,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of PKI. Kentucky Retirement Systems boosted its stake in PerkinElmer by 0.9% in the third quarter. Kentucky Retirement Systems now owns 6,584 shares of the medical research company’s stock worth $1,141,000 after purchasing an additional 57 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in PerkinElmer by 1.1% in the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 6,843 shares of the medical research company’s stock worth $1,375,000 after purchasing an additional 76 shares in the last quarter. Cambridge Investment Research Advisors Inc. boosted its stake in PerkinElmer by 1.3% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 6,075 shares of the medical research company’s stock worth $1,221,000 after purchasing an additional 77 shares in the last quarter. Empirical Finance LLC boosted its stake in PerkinElmer by 5.9% in the third quarter. Empirical Finance LLC now owns 1,393 shares of the medical research company’s stock worth $241,000 after purchasing an additional 78 shares in the last quarter. Finally, Mutual of America Capital Management LLC boosted its stake in PerkinElmer by 0.6% in the third quarter. Mutual of America Capital Management LLC now owns 14,699 shares of the medical research company’s stock worth $2,547,000 after purchasing an additional 93 shares in the last quarter. Institutional investors and hedge funds own 81.95% of the company’s stock.

In other PerkinElmer news, insider Daniel R. Tereau sold 6,696 shares of the stock in a transaction dated Monday, March 14th. The stock was sold at an average price of $165.84, for a total value of $1,110,464.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.52% of the stock is owned by corporate insiders.

Separately, StockNews.com started coverage on PerkinElmer in a research report on Thursday, March 31st. They set a “hold” rating for the company. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, PerkinElmer currently has an average rating of “Buy” and a consensus price target of $166.37.

NYSE PKI traded down $5.78 on Monday, reaching $146.81. The company had a trading volume of 29,546 shares, compared to its average volume of 853,445. The stock’s 50 day moving average is $172.73 and its 200-day moving average is $177.96. The stock has a market cap of $18.52 billion, a price-to-earnings ratio of 18.88, a PEG ratio of 0.50 and a beta of 1.10. The company has a quick ratio of 1.50, a current ratio of 2.01 and a debt-to-equity ratio of 0.70. PerkinElmer, Inc. has a 52 week low of $126.75 and a 52 week high of $203.16.

PerkinElmer (NYSE:PKIGet Rating) last released its quarterly earnings data on Tuesday, February 1st. The medical research company reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.15 by $0.41. The business had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.32 billion. PerkinElmer had a return on equity of 23.73% and a net margin of 18.40%. The firm’s revenue was up .7% on a year-over-year basis. During the same quarter in the prior year, the company posted $3.96 earnings per share. As a group, analysts forecast that PerkinElmer, Inc. will post 6.92 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 13th. Shareholders of record on Friday, April 22nd will be issued a $0.07 dividend. The ex-dividend date of this dividend is Thursday, April 21st. This represents a $0.28 annualized dividend and a dividend yield of 0.19%. PerkinElmer’s dividend payout ratio (DPR) is currently 3.47%.

PerkinElmer Profile (Get Rating)

PerkinElmer, Inc provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services.

Featured Stories

Want to see what other hedge funds are holding PKI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PerkinElmer, Inc. (NYSE:PKIGet Rating).

Institutional Ownership by Quarter for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.